A randomised clinical trial of STAtin therapy for Reducing Events in the Elderly (STAREE): Statistical analysis plan.
Wolfe, R.; Heritier, S.; Zomer, E.; Chatterton, M. L.; Curtis, A.; Spark, S.; Flanagan, Z.; Chong, T. T.-J.; Cloud, G. C.; Nelson, M. R.; Nicholls, S. J.; Moran, C.; Reid, C. M.; Zoungas, S.; On behalf of The STAREE Investigator Group,
Show abstract
The STAREE randomised controlled trial of 9971 community-dwelling older adults without cardiovascular disease, diabetes or dementia is designed to compare daily 40mg atorvastatin to placebo. We present a statistical analysis plan to pre-specify the analytical approaches that will be taken when reporting the main findings from the trial. The plan describes the analysis approach for the co-primary endpoints: (a) death, dementia, and persistent physical disability; (b) major cardiovascular events; and all secondary endpoints. A pre-specified economic evaluation is also included as part of this plan.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Real-world effects of ACE inhibitors and Angiotensin Receptor Blockers: protocol for an emulation study of the ONTARGET trial using electronic health records 96%
- CATALYST trial protocol: A multicentre, open-label, phase II, multi-arm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults 92%
- Effects of 12 weeks of Multi-nutrient supplementation on the Immune and Musculoskeletal systems of Older Adults in Aged-Care (The Pomerium Study): Protocol for a Randomised Controlled Trial 92%
Similar papers in this journal
- A Retrospective Analysis of Serious Adverse Events and Deaths in US-Based Lifestyle Clinical Trials for Cognitive Health 93%
- The Helping Older People Engage (HOPE) Study: Protocol & COVID Modifications for a Randomized Trial 90%
- Erroneous risks in pharmaceutical versus non-pharmaceutical interventions during data extraction in evidence synthesis practice: Study protocol for a randomized controlled trial 90%
Similar papers in this journal
- STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: a structured protocol 95%
- Investigating the use of a one-page infographic to improve recruitment and retention to the BASIL+ Randomised Controlled Trial: A Study Within a Trial (SWAT) 93%
- Determining Cost-Saving Risk Thresholds for Statin Use 92%
Similar papers in this journal
- Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): Statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial 96%
- Evaluating Diuretics in Normal Care (EVIDENCE): Protocol of a cluster randomised controlled equivalence trial of prescribing policy to compare the effectiveness of thiazide-type diuretics in hypertension. 92%
- The iHealth-T2D study: Statistical analysis plan for a cluster randomised controlled trial with intensive family-based lifestyle modification programme to reduce type 2 diabetes risk amongst South Asians 92%
Similar papers in this journal
- Quantifying absolute treatment effect heterogeneity for time-to-event outcomes across different risk strata: divergence of conclusions with risk difference and restricted mean survival difference 90%
- Tools for the assessment of quality and risk of bias in Mendelian randomization studies: a systematic review 89%
- Investigating the transparency of reporting in two-sample summary data Mendelian randomization studies 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.